BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27146587)

  • 21. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
    Bijker N; Peterse JL; Duchateau L; Julien JP; Fentiman IS; Duval C; Di Palma S; Simony-Lafontaine J; de Mascarel I; van de Vijver MJ
    J Clin Oncol; 2001 Apr; 19(8):2263-71. PubMed ID: 11304780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Westenberg AH; Rutgers EJ; Peterse JL; Hendriks JH; Beex LV; van Tienhoven G
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2157-61. PubMed ID: 14626831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
    Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; EspiƩ M; Cuvier C
    Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
    Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
    Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
    Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
    Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
    Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
    Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Vicini FA; Shaitelman S; Wilkinson JB; Shah C; Ye H; Kestin LL; Goldstein NS; Chen PY; Martinez AA
    Breast J; 2013; 19(4):365-73. PubMed ID: 23815268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ.
    Davis JE; Nemesure B; Mehmood S; Nayi V; Burke S; Brzostek SR; Singh M
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):20-5. PubMed ID: 26317313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
    Cheung S; Booth ME; Kearins O; Dodwell D
    Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.
    Fish EB; Chapman JA; Miller NA; Link MA; Fishell E; Wright B; McCready DR; Hiraki GY; Ross TM; Hanna WM; Lickley HL
    Ann Surg Oncol; 1998 Dec; 5(8):724-32. PubMed ID: 9869520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    Julien JP; Bijker N; Fentiman IS; Peterse JL; Delledonne V; Rouanet P; Avril A; Sylvester R; Mignolet F; Bartelink H; Van Dongen JA
    Lancet; 2000 Feb; 355(9203):528-33. PubMed ID: 10683002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and predictive molecular markers in DCIS: a review.
    Nofech-Mozes S; Spayne J; Rakovitch E; Hanna W
    Adv Anat Pathol; 2005 Sep; 12(5):256-64. PubMed ID: 16210921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of a prior diagnosis of DCIS on survival from invasive breast cancer.
    Sopik V; Iqbal J; Sun P; Narod SA
    Breast Cancer Res Treat; 2016 Jul; 158(2):385-93. PubMed ID: 27383477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ.
    Hwang ES; Miglioretti DL; Ballard-Barbash R; Weaver DL; Kerlikowske K;
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2587-93. PubMed ID: 18086762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ.
    Mori K; Takeda M; Kodama Y; Kiyokawa H; Yasojima H; Mizutani M; Otani Y; Morikawa N; Masuda N; Mano M
    Hum Pathol; 2017 Jun; 64():145-155. PubMed ID: 28434924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
    Rakovitch E; Nofech-Mozes S; Hanna W; Baehner FL; Saskin R; Butler SM; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Robertson SJ; Slodkowska E; Fong C; Anderson JM; Jamshidian F; Miller DP; Cherbavaz DB; Shak S; Paszat L
    Breast Cancer Res Treat; 2015 Jul; 152(2):389-98. PubMed ID: 26119102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.